Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and marketing therapies for acute care and oncology supportive care. The company’s current portfolio includes products used to help manage post-surgical pain and to prevent nausea and vomiting associated with surgery and cancer treatment. Its marketed medicines are designed for use in clinical settings and are sold primarily through healthcare providers, hospitals, and other medical institutions. Heron Therapeutics relies on proprietary drug delivery and formulation capabilities to support its branded prescription products, which serve specialized patient needs in perioperative care and oncology. The company operates in the U.S. specialty pharmaceutical market and is positioned around targeted treatments that address common complications of medical procedures and cancer therapy.

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Craig Alexander Collard

Employees

128

Headquarters

Cary, NC, United States

Website

www.herontx.com